(Reuters) – U.S. biotech firm Moderna said on Monday it had submitted a regulatory application to the European Medicines Agency (EMA) seeking authorization for its updated COVID-19 vaccine to target the XBB.1.5 sub-variant.
(Reporting by Eva Mathews in Bengaluru; Editing by Rashmi Aich)
